liraglutide vs retatrutide UK 2026: Phase 3 Results Eli Lilly's retatrutide shows promising

Supporting healthy cell growth and repair

Source - stockscans.in Look at the numbers that rolled in across Q4 FY26 earnings season: median revenue growth for the listed pharma universe is comfortably in double digits consecutively for 2 qtrs in a row now which has happened almost after 10 qtrs now

Long-term therapeutic benefits were also evident

People with Type 2 diabetes often have an abundance of visceral (intra-abdominal) fat, as well as fat in and around the liver, heart, skeletal muscle, kidneys and other organs

Options include slowing dose escalation, temporarily pausing the medication while we treat your eyes, or switching to alternative diabetes therapies